» Articles » PMID: 20697288

Size of the Direct-to-consumer Genomic Testing Market

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2010 Aug 11
PMID 20697288
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

There has been enormous interest in the recent development of consumer genomics services, but very little is known about their impact. Using publicly available information, we estimate that the market for genetic susceptibility tests for complex diseases is much smaller than previously suggested, and hence consider that regulation through restrictive statutory legislation may be excessive.

Citing Articles

Valuable Genomes: Taxonomy and Archetypes of Business Models in Direct-to-Consumer Genetic Testing.

Thiebes S, Toussaint P, Ju J, Ahn J, Lyytinen K, Sunyaev A J Med Internet Res. 2020; 22(1):e14890.

PMID: 31961329 PMC: 7001042. DOI: 10.2196/14890.


Beyond clinical utility: The multiple values of DTC genetics.

Turrini M, Prainsack B Appl Transl Genom. 2016; 8:4-8.

PMID: 27047753 PMC: 4796703. DOI: 10.1016/j.atg.2016.01.008.


Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers.

Mavroidopoulou V, Xera E, Mollaki V J Hum Genet. 2015; 60(9):515-23.

PMID: 26040209 DOI: 10.1038/jhg.2015.58.


The mathematical limits of genetic prediction for complex chronic disease.

Keyes K, Davey Smith G, Koenen K, Galea S J Epidemiol Community Health. 2015; 69(6):574-9.

PMID: 25648993 PMC: 4430395. DOI: 10.1136/jech-2014-204983.


Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk.

Anderson A, Flores K, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham W Public Health Genomics. 2014; 17(1):48-60.

PMID: 24435063 PMC: 3992284. DOI: 10.1159/000356567.